SGO Issues September 25, 2014
Call for Abstracts open for 2015 SGO Winter Meeting
Autumn is SGO membership renewal season
2015 SGO International Scholar Travel Grants deadline Oct. 25
AJCC confirms Jonathan Cosin as new SGO liaison
Abu-Rustum testifies to recognize Ovarian Cancer Awareness Month
ASTRO releases second Choosing Wisely list
Young investigators are invited to submit research now through Nov. 10, 2014, for consideration for presentation in a special Poster Session at the 20th Annual SGO Winter Meeting at the Snowbird Resort in Snowbird, UT, Feb. 19-21, 2015. Acceptance letters will be sent out in mid-December.
The three-day course, led by course directors John Brown, MD, FACOG, FACS, and William Peters, III, MD, will address topics concerning complementary medicine, minimally invasive surgery, ovarian cancer, innovative uses of technology. The meeting will include special sessions, like the Tumor Board and poster presentations by Residents and Fellows-in-Training.
Gynecologic Oncologists, Radiation Oncologists, Medical Oncologists, Obstetricians and Gynecologists, and Allied Health Professionals involved in the care of patients who have gynecologic cancers are encouraged to attend.
A preliminary schedule of events for the 2015 SGO Winter Meeting is available here.
It’s time to renew your SGO membership. Don’t miss your opportunity to access new membership resources including the online e-learning platform, SGO ConnectEd, which has been updated to fit your needs. Click here to renew your membership online today.
In the coming week, you will receive your 2015 membership dues renewal statement. The SGO Membership Committee, SGO leadership and staff thank you for your continued support and involvement with SGO. Please contact SGO’s membership department if you have questions or need assistance at email@example.com or 312-235-4060.
SGO is offering three International Scholar Travel Grants to assist multidisciplinary early career professionals involved in the prevention, research, treatment or care of gynecologic cancers. Scholarship applications are being accepted now through Oct. 25. The scholarship provides up to $3,300 USD for travel and lodging expenses to attend the SGO Annual Meeting on Women’s Cancer® in Chicago, Illinois, March 28-31, 2015.
To apply for the program, please , complete and send to firstname.lastname@example.org. If you have any questions, please contact Kristin Belleson, Director of Membership Engagement and Services, at 00 1 (312) 235-4058.
The American Joint Committee on Cancer (AJCC) Executive Committee on Sept. 12 confirmed Jonathan A. Cosin, MD, FACOG, FACS, of the Hartford Health Care Cancer Institute, as the new SGO liaison. He succeeds Alexander B. Olawaiye, MD, FACS, MRCOG, FACOG, who has completed his second three-year term.
Dr. Olawaiye, from the University of Pittsburgh, will continue his work with the AJCC as Dr. Cosin’s mentor and Vice Chair of the AJCC’s Gynecologic Cancer Expert Panel. The panel is chaired by David Mutch, MD, of Washington University in St. Louis. Drs. Cosin and Olawaiye collaborated with Dr. Mutch and Joshua P. Kesterson, MD, of the Penn State College of Medicine, on the fourth edition of SGO’s Staging of Gynecologic Malignancies Handbook, which was published last month.
Dr. Olawaiye noted that although gynecologic cancer staging is produced by the International Federation of Gynecology and Obstetrics (FIGO), all U.S. data and registries relevant to patient care and research are based on the AJCC staging system.
“Overall, AJCC is considered one of the foremost staging authorities worldwide, and any new changes by FIGO are presented to the AJCC for endorsement and/or suggestions prior to finalization,” said Dr. Olawaiye. “It is therefore critical for SGO—the custodian of gynecologic cancer care—to be represented at the AJCC, since we are considered the gynecologic cancer ‘voice’ of the AJCC.”
“AJCC is currently in the process of working on its eighth edition Cancer Staging Manual, which will include updates to all of the cancer staging systems,” said Dr. Cosin. “For gynecologic oncology, this notably includes ovarian cancer, which recently underwent an extensive revision by FIGO. I look forward to working with AJCC on this and representing SGO’s point of view.”
Dr. Cosin added that the staging of cancers plays a vital role in the treatment of cancer.
“At its simplest, staging helps us compare treatments across institutions and borders,” he said. “As our understanding of cancer becomes more complex and we move beyond our microscopic understanding and into the age of molecular science, staging systems have not only the responsibility to keep up, but also a responsibility to lead the way forward.”
On Sept. 23 the New York City Council passed Resolution 380 to declare September Ovarian Cancer Awareness Month. Nadeem Abu-Rustum, MD, of Memorial Sloan Kettering Cancer Center, testified in favor of this resolution before the Council’s Health Committee on Sept. 18 and took part in a panel discussion.
“As someone who treats women with ovarian cancer, I am all-too familiar with the devastating effect of this disease,” Dr. Abu-Rustum told the committee. “Awareness efforts in New York City may lead to earlier diagnoses, appropriate referral and more positive outcomes for women with ovarian cancer.”
Patient advocates who testified in favor of the resolution included Pamela Esposito-Amery, Co-Founder & CEO of Tell Every Amazing Lady About Ovarian Cancer (T.E.A.L.); Jacqueline Reinhard, Executive Director of SHARE; Lisa Franklin, SHARE ambassador and Ovarian Cancer survivor; Kitty Silverman, National Ovarian Council Coalition (NOCC) NYC Regional Chapter Manager; and Andrew Brozman, Director of Tina’s Wish Foundation.
On Sept. 15, the American Society for Radiation Oncology (ASTRO) released its second list of five radiation oncology-specific treatments that are commonly ordered but may not always be appropriate, as part of the national Choosing Wisely® campaign, an initiative of the ABIM Foundation. Two of these recommendations are related to endometrial cancer and palliative care.
ASTRO’s Choosing Wisely list identifies five targeted treatment options that ASTRO recommends for detailed patient-physician discussion before being prescribed. ASTRO released its first list of five recommendations on Sept. 23, 2013.
ASTRO’s 2014 list of five recommendations are:
- Don’t recommend radiation following hysterectomy for endometrial cancer patients with low-risk disease.
- Don’t routinely offer radiation therapy for patients who have resected non-small cell lung cancer (NSCLC), negative margins, N0-1 disease.
- Don’t initiate non-curative radiation therapy without defining the goals of treatment with the patient and considering palliative care referral.
- Don’t routinely recommend follow-up mammograms more often than annually for women who have had radiotherapy following breast conserving surgery.
- Don’t routinely add adjuvant whole brain radiation therapy to stereotactic radiosurgery for limited brain metastases.
An explanation of each of these recommendations is available on the Choosing Wisely website.